Premium
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
Author(s) -
Herr Harry W.,
Kornblith Alice B.,
Ofman Ursula
Publication year - 1993
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i
Subject(s) - medicine , hormonal therapy , quality of life (healthcare) , asymptomatic , psychosocial , prostate cancer , cancer , oncology , nursing , psychiatry
Background and Methods . The quality of life in patients who elected to receive hormonal therapy for newly diagnosed asymptomatic metastatic prostate cancer was compared with a comparable group of patients who chose to defer immediate intervention. Results and Conclusions . The premise that active therapy, despite its side effects, would improve or maintain the psychosocial quality of life was not substantiated, and the no‐therapy group had better physical and sexual functioning.